期刊文献+

RGS5和ATP1B1基因与原发性高血压的相关性研究 被引量:1

Association between RGS5 and ATP1B1 and essential hypertension
下载PDF
导出
摘要 目的探讨中国汉族人群中G蛋白信号调节因子5(RGS5)和ATP1B1基因功能区标签单核苷酸多态性(SNP)与原发性高血压的相关性及变异位点间的交互作用。方法选择启动子、外显子和3’UTR区符合最小等位基因频率在中国北京汉族人群中>5%、R2≥0.80的SNP。对906例原发性高血压患者(EH组)进行SNP位点的基因分型,以性别和年龄与EH组匹配的894名血压正常者作为正常对照组。观察不同基因型和等位基因频率在EH组和对照组中的分布,并采用MDR软件分析各位点之间的交互作用。结果最终3个标签SNP入选。EH组与对照组SNP位点基因型分布和等位基因频率比较差异无统计学意义(P>0.05);由2个基因SNP位点组成的单倍型,在EH组和对照组的分布比较差异也无统计学意义(P>0.05)。交互作用分析显示,2个或3个位点模型比较差异均无统计学意义(P>0.05)。结论3个标签SNP与EH无明显相关性,并且可能不存在交互作用。 Objective To explore the relationship between functional single nucleotide polymorphisms(SNPs)of regulator of G-protein signaling 5(RGS5)and ATP1B1 and essential hypertension,as well as the interaction among genetic variations in Chinese Han populations.Methods Tag-SNPs in promoter,exons and 3'UTR with minor allele frequency 〉5% in the Chinese Han population in Beijing were selected to capture the common variation in or around this gene with a minimum R^2 of 0.80.Tag single SNPs of RGS5 and ATP1B1 were genotyped in 906 patients with essential hypertension(EH group)and 894 age-and gender-matched normotensive controls(control group).The allelic frequency and genotype distribution between EH group and control group were analysed.MDR software was employed to analyse the interaction between SNPs selected.Results Three SNPs were selected and genotyped.There was no significant difference in the allelic frequency and genotype distribution between EH group and normal control group(P〉0.05).Haplotype-based analysis revealed no significant difference for the haplotype distribution between EH group and normal control group(P〉0.05).There was no significant difference in the interaction model between two and three SNPs analysed by MDR(P〉0.05).ConclusionThere is no significant association between 3 SNPs selected and EH,and there may be no interactions among them.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第9期1022-1025,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家高技术研究发展计划("863"计划)(2006AA02Z179) 国家重点基础研究发展计划("973"计划)(2004CB518603)~~
关键词 G蛋白信号调节因子5 ATP1B1 多态性 原发性高血压 regulator of G-protein signaling 5 ATP1B1 polymorphism essential hypertension
  • 相关文献

参考文献11

  • 1Chang YP, Liu X, Kim JD, et al. Multiple genes for essentialhypertension susceptibility on chromosome 1q [ J ].Am J Hum Genet, 2007, 80(2): 253-264.
  • 2Perola M, Kainulainen K, Pajukanta P, et al. Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings[ J]. J Hypertens, 2000, 18( 11 ) : 1579 - 1585.
  • 3DiPetrillo K, Tsaih SW, Sheehan S, et al. Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice[J]. Physiol Genomics, 2004, 17(2) : 215 -220.
  • 4Cho H, Kozasa T, Bondjers C, et al. Pericyte-specific expression of RGS5: implications for PDGF and EDG receptor signaling during vascular maturation[J]. FASEB J, 2003, 17(8) : 440 -442.
  • 5Wang X, Adams LD, Pabon LM, et al. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy[J]. J Mol Cell Cardiol, 2008, 44(3) : 539 -550.
  • 6Gong M, Hubner N. Molecular genetics of human hypertension[ J]. Clin Sci(Lond), 2006, 110(3) : 315 -326.
  • 7de Bakker PI, Yelensky R, Pe'er I, et al. Efficiency and power in genetic association studies [ J ]. Nat Genet, 2005, 37 ( 11 ) : 1217 - 1223.
  • 8Grayson TH, Ohms SJ, Brackenbury TD, et al. Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets[ J]. BMC Genomics, 2007, 8: 404.
  • 9Cho H, Park C, Hwang IY, et al. Rgs5 targeting leads to chronic low blood pressure and a lean body habitus [ J]. Mol Cell Biol, 2008, 28 (8) : 2590 - 2597.
  • 10Moore JH. Computational analysis of gene-gene interactions using muhifactor dimensionality reduction [ J]. Expert Rev Mol Diagn, 2004, 4(6) : 795 -803.

二级参考文献12

  • 1Moore JH.The ubiquitous nature of epistasis in determining susceptibility to common human diseases.Hum Hered,2003,56:73-82.
  • 2Moore JH,Ritchie MD.The challenges of whole-genome approaches to common diseases.JAMA,2004,291:1642-1643.
  • 3Ritchie MD,Hahn LW,Roodi N,et al.Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.Am J Hum Genet,2001,69:138-147.
  • 4Hahn LW,Ritchie MD,Moore JH.Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.Bioinformatics,2003,19:376-382.
  • 5Nelson MR,Kardia SL,Ferrell RE,et al.A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation.Genome Res,2001,11:458-470.
  • 6Coffey CS,Hebert PR,Ritchie MD,et al.An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction:the importance of model validation.BMC Bioinformatics,2004,5:49.
  • 7Moore JH.Computational analysis of gene-gene interactions using multifactor dimensionality reduction.Expert Rev Mol Diagn,2004,4:795-803.
  • 8Robnik-Sikonja M,Kononenko I.Theoretical and empirical analysis of Relief F and RRelief F.Mach Lear J,2003,53:23-69.
  • 9Tsai CT,Lai LP,Lin JL,et al.Renin-angiotensin system gene polymorphisms and atrial fibrillation.Circulation,2004,109:1640-1646.
  • 10Hahn LW,Moore JH.Ideal discrimination of discrete clinical endpoints using multilocus genotypes.In Silico Biol,2004,4:183-194.

共引文献29

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部